Voloridge Investment Management, LLC Fate Therapeutics Inc Transaction History

Voloridge Investment Management, LLC

$25.9 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.12 - $5.57 $119,783 - $213,843	-38,392 Reduced 37.53%	63,903 $223,000
Q2 2024 Aug 14, 2024	SELL	$3.26 - $7.08 $900,780 - $1.96 Million	-276,313 Reduced 72.98%	102,295 $335,000
Q1 2024 May 15, 2024	BUY	$3.54 - $8.35 $1.34 Million - $3.16 Million	378,608 New	378,608 $2.78 Million
Q2 2023 Aug 14, 2023	SELL	$4.76 - $6.59 $2.97 Million - $4.12 Million	-624,959 Reduced 42.83%	834,324 $3.97 Million
Q1 2023 May 15, 2023	BUY	$4.24 - $11.12 $3.94 Million - $10.3 Million	928,247 Added 174.8%	1,459,283 $8.32 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $83,435 - $201,649	8,462 Added 1.62%	531,036 $5.36 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $934,617 - $1.6 Million	44,421 Added 9.29%	522,574 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$17.78 - $42.39 $4.61 Million - $11 Million	259,435 Added 118.62%	478,153 $11.8 Million
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $1.53 Million - $3.1 Million	-51,402 Reduced 19.03%	218,718 $8.48 Million
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $6.96 Million - $9.37 Million	145,574 Added 116.88%	270,120 $15.8 Million
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $6.78 Million - $11 Million	114,447 Added 1133.25%	124,546 $7.38 Million
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $679,157 - $934,359	10,099 New	10,099 $876,000
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $2.54 Million - $4.13 Million	-35,218 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $276,266 - $732,190	7,253 Added 25.94%	35,218 $3.2 Million
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $850,415 - $1.13 Million	27,965 New	27,965 $1.12 Million
Q2 2020 Aug 14, 2020	SELL	$20.21 - $35.23 $690,494 - $1.2 Million	-34,166 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $590,388 - $1.09 Million	34,166 New	34,166 $759,000

Others Institutions Holding FATE

# of Institutions

167

Shares Held

101M

Call Options Held

41.3K

Put Options Held

15.9K

Redmile Group, LLC San Francisco, CA

12.9M
Shares

$11.7 Million
1.66% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$9.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$9.21 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

4.84M
Shares

$4.4 Million
0.16% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

4.38M
Shares

$3.99 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $88.3M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account